MP39-13 AN OPEN-LABEL, TWO-PART, SEQUENTIAL DOSE STUDY ASSESSING THE ABSOLUTE BIOAVAILABILITY, MASS BALANCE, AND RECOVERY FOR [14C]-ROSIPTOR (AQX-1125) IN HEALTHY SUBJECTS Article Swipe
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1016/j.juro.2018.02.1260
· OA: W2796360260
You have accessJournal of UrologyInfections/Inflammation/Cystic Disease of the Genitourinary Tract: Interstitial Cystitis1 Apr 2018MP39-13 AN OPEN-LABEL, TWO-PART, SEQUENTIAL DOSE STUDY ASSESSING THE ABSOLUTE BIOAVAILABILITY, MASS BALANCE, AND RECOVERY FOR [14C]-ROSIPTOR (AQX-1125) IN HEALTHY SUBJECTS Patrick Tam, Dorothea Scholl, Judy Toews, Curtis Harwig, and Lloyd F Mackenzie Patrick TamPatrick Tam More articles by this author , Dorothea SchollDorothea Scholl More articles by this author , Judy ToewsJudy Toews More articles by this author , Curtis HarwigCurtis Harwig More articles by this author , and Lloyd F MackenzieLloyd F Mackenzie More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.1260AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail WITHDRAWN © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e515 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Patrick Tam More articles by this author Dorothea Scholl More articles by this author Judy Toews More articles by this author Curtis Harwig More articles by this author Lloyd F Mackenzie More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
